<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-140969" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Palliative Radiation Therapy For Bone Metastases</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Garbar</surname>
            <given-names>Veronica</given-names>
          </name>
          <aff>Florida Atlantic University General Surgery Residency</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Richter</surname>
            <given-names>Samuel</given-names>
          </name>
          <aff>Lynn Cancer Institute - Baptist Health South Florida</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Veronica Garbar declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Samuel Richter declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>10</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-140969.s1" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>Bone&#x000a0;is the site of metastases for many cancers during tumor pathogenesis. The incidence of new cases of bone metastases is estimated to be about 280,000 annually in the United States.&#x000a0;Most notably, breast (65% to 75%), prostate cancer (65% to 90%), lung cancer (17% to 64%), and to a lesser extent, bladder cancer (40%), thyroid cancer (65%), melanoma (14% to 45%), kidney cancer (20% to 25%), and colorectal cancer (10%) favor metastases to the bone. Multiple myeloma accounts for about 70% to 95% of bone lesions.<xref ref-type="bibr" rid="article-140969.r1">[1]</xref>&#x000a0;</p>
        <p>The structural bone damage&#x000a0;that ensues leads to significant pain, pathologic fractures, and decreased quality of life.<xref ref-type="bibr" rid="article-140969.r2">[2]</xref>&#x000a0;Metastasis can occur in&#x000a0;3 main anatomic locations: the extremities, pelvis, and spine. The most common site of metastatic bone lesions is the spine.&#x000a0;The most common location is the thoracic spine (60% to 70%) of the spinal columns. The lumbosacral spine accounts for 20% to 25%, followed by the cervical spine with 10% to 15% of spinal metastasis.<xref ref-type="bibr" rid="article-140969.r3">[3]</xref><xref ref-type="bibr" rid="article-140969.r4">[4]</xref><xref ref-type="bibr" rid="article-140969.r5">[5]</xref><xref ref-type="bibr" rid="article-140969.r6">[6]</xref><xref ref-type="bibr" rid="article-140969.r7">[7]</xref>&#x000a0;The upper extremity accounts for about 24%, whereas the lower extremity accounts for about 76% of the long bone metastases.<xref ref-type="bibr" rid="article-140969.r8">[8]</xref></p>
        <p>The primary reason for treating bone metastases is to prevent further skeletal injury and improve symptoms. Generally, surgical treatment options are offered to patients with a life expectancy greater than 6 weeks. Those with a life expectancy of 3 to 12 months&#x000a0;are treated with minimally invasive surgery. En bloc resection of metastatic lesions may be the best option for patients with a life expectancy of 12 months or more.<xref ref-type="bibr" rid="article-140969.r9">[9]</xref><xref ref-type="bibr" rid="article-140969.r10">[10]</xref>&#x000a0;For patients who do not fall into the surgical treatment category, palliative radiation therapy of the bony metastases&#x000a0;is a viable treatment option.</p>
      </sec>
      <sec id="article-140969.s2" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>Healthy bone is in a constant state of turnover. Bone is deposited by osteoblasts, with absorption occurring via osteoclasts. Osteoclasts function under the influence of parathyroid hormone and calcitonin in response to calcium levels. Osteoclasts secrete enzymes and acids to mediate bone deposition and formation.&#x000a0;Bone metastasis occurs due to growth at the primary tumor site, leading to tumor neovascularization. Tumor cells then detach from the primary tumor bed and invade nearby tissues with invasion into the blood. The tumor cells that survive in circulation then enter the bone marrow.&#x000a0;In the bone marrow, the cells evade host defenses and further growth with stimulation of osteoclasts, leading to further bone resorption.<xref ref-type="bibr" rid="article-140969.r11">[11]</xref>&#x000a0;Cancer cells can release a whole host of growth factors that propagate osteoclasts. In addition, bone metastasis produces an increased inflammatory cell response, resulting in pain. The other mechanisms of bone pain relate to infiltration of the nerve root, microfractures, stretching of the periosteum, increased pressure in the bone, muscle spasms, and nerve compression.<xref ref-type="bibr" rid="article-140969.r12">[12]</xref></p>
      </sec>
      <sec id="article-140969.s3" sec-type="Indications">
        <title>Indications</title>
        <p>The primary goal of palliative radiation therapy is to alleviate pain. After treatment, most patients will expect to experience pain relief in&#x000a0;2 to&#x000a0;3 weeks in 60% of patients.<xref ref-type="bibr" rid="article-140969.r13">[13]</xref><xref ref-type="bibr" rid="article-140969.r14">[14]</xref>&#x000a0;The indications for palliative radiotherapy to bone metastasis include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Pain from bone metastases&#x000a0;that is difficult to control with oral regimens</p>
          </list-item>
          <list-item>
            <p>Malignant spinal cord compression</p>
          </list-item>
          <list-item>
            <p>Prevention of pathologic fractures</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140969.s4" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>Contraindications to radiotherapy include patients with a history of inflammatory bowel disease, collagen vascular disease, pregnancy, and those with inherited cancer predisposition syndromes (eg, Down syndrome, Fanconi anemia, Gorlin syndrome, Cockayne syndrome, Gardner syndrome, Usher syndrome, Ataxia-telangiectasia, and Nijmegen breakage syndrome).<xref ref-type="bibr" rid="article-140969.r15">[15]</xref>&#x000a0;In addition, patients must be able to tolerate laying still for short periods. Patients must be able to provide informed consent for the procedure. Patients must be able to abide by verbal commands from radiation technicians in the adjacent room. The patient should have reasonable follow-up to monitor the effectiveness of pain control and adverse effects.<xref ref-type="bibr" rid="article-140969.r16">[16]</xref></p>
      </sec>
      <sec id="article-140969.s5" sec-type="Personnel">
        <title>Personnel</title>
        <p>To design radiotherapy treatment, the radiation oncology team includes:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Radiation oncologists</bold>: Board-certified&#x000a0;clinicians in radiology oncology evaluate patients with various cancers for radiation therapy.</p>
          </list-item>
          <list-item>
            <p><bold>Dosimetrists</bold>: Licensed health professionals who design the most potent radiation dosing possible for the area of interest with the fewest adverse effects of radiation.</p>
          </list-item>
          <list-item>
            <p><bold>Medical physicists</bold>: Certified in therapeutic medical physics, these individuals work with dosimetrists to create effective treatment plans based on tumor location to deliver potent radiation with minimal healthy tissue involvement. Physicists ensure that the treatment plan is the actual plan delivered with the machine through a series of quality assurance checks before the patient is treated.</p>
          </list-item>
          <list-item>
            <p><bold>Radiation therapists</bold>: These licensed therapists operate the machinery required to deliver treatment.</p>
          </list-item>
          <list-item>
            <p><bold>Radiation oncology nurses and support staff</bold>: Specialized team members responsible for aiding in simulation setup, scheduling, and patient management.</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140969.s6" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>
<bold>Radiotherapy Administration</bold>
</p>
        <p>A dedicated center uses a linear accelerator to deliver high-energy x-rays to the target lesion. Before receiving treatment, patients are&#x000a0;examined in a consultation session termed simulation. During simulation, the patient is placed in an optimal position to treat the target lesion. The position must balance patient comfort, tolerance, and reproducibility at future appointments. The patient is expected to be in nearly the same position for all treatment appointments. Typically, patients must be able to lie still for roughly 15 to 30 minutes to complete a single treatment. A patient may need to wear a tight-fitting mask or garment when treating upper neck, head, and chest lesions. These high-energy beams delivered during treatment cause DNA damage and lead to cell death. Most patients undergoing curative treatment&#x000a0;are scheduled to receive small daily doses called fractions. The fragmentation of radiotherapy treatment into smaller fractions reduces harm to healthy tissue near the target lesion and aids in avoiding permanent adverse effects. Patients undergoing palliative treatments typically receive a lower total dose, shifting the focus to symptom management of pain. The result for a patient receiving palliative radiotherapy is a shorter duration of a larger fraction.<xref ref-type="bibr" rid="article-140969.r16">[16]</xref></p>
        <p>
<bold>Radiotherapy Techniques</bold>
</p>
        <p>The primary radiotherapy techniques utilized are three-dimensional conformal radiation therapy (3-DCRT) and stereotactic body radiation (SBRT). The 3-DCRT external beam technique first requires a computed tomography (CT) scan of the target lesion and surrounding anatomy. In the case of spine metastasis to a vertebral body, the desired dose to the target volume is delivered to the site of the bone metastasis, including the vertebral body, often including a vertebral level above and below the lesion. Using 3-DCRT&#x000a0;spares neighboring critical organs at risk.<xref ref-type="bibr" rid="article-140969.r17">[17]</xref>&#x000a0;However, SBRT delivers high doses of radiation to the target lesion with greater accuracy. This treatment modality allows minimal dose to surrounding structures in the treatment field and involves only the tumor.<xref ref-type="bibr" rid="article-140969.r18">[18]</xref><xref ref-type="bibr" rid="article-140969.r19">[19]</xref>&#x000a0;SBRT is used less often than external beam radiation therapy (EBRT), but SBRT is useful for bone metastasis that is highly radioresistant (eg, sarcoma, renal cell carcinoma, and melanoma) or in the case of oligometastatic disease.</p>
        <p>As of July 2023, a new study evaluated SBRT with EBRT for patients with painful spine metastases. The trial included 339 randomized patients with&#x000a0;1 to&#x000a0;3 spinal metastases where a pain response was measured on an 11-point scale. The results showed that EBRT elicited a complete or partial pain response more commonly than SBRT (61% versus 41%). EBRT continues to be used for most patients with a finite number of spinal bone metastases.<xref ref-type="bibr" rid="article-140969.r20">[20]</xref></p>
        <p>
<bold>Recommended Treatment Course</bold>
</p>
        <p>The American Society for Radiation Oncology (ASTRO) recommends single-fraction EBRT with 8 Gy for palliative pain relief of bone metastases. Fractionation schedules lead to higher costs and patient inconvenience than a single-fraction treatment plan.<xref ref-type="bibr" rid="article-140969.r21">[21]</xref>&#x000a0;An updated review of high-quality data shows pain relief equivalency following a single 8 Gy fraction, 20 Gy in 5 fractions, 24 Gy in 6 fractions, and 30 Gy in 10 fractions for patients with previously unirradiated painful bone metastases. Patients should be aware that single-fraction radiotherapy is associated with a higher incidence of retreatment to the same painful site&#x000a0;compared to fractionated treatment.<xref ref-type="bibr" rid="article-140969.r22">[22]</xref></p>
        <p>At times, surgery may be required before beginning radiation in patients who experience pathologic fracture of the long bones. Surgery may also be performed prophylactically to prevent pathologic fracture occurrence. Should a patient undergo surgical stabilization, radiotherapy is often administered postoperatively to provide local control of disease and alleviate associated pain. Several scoring systems have been developed to provide a more objective way of predicting patients' fracture risk with metastatic disease to long bones and vertebral lesions, including:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Mirels scoring system:</bold> This scoring system considers the patient's level of cortex involvement, site of bone metastasis, radiographic nature, and pain level to attribute a score.&#x000a0;The system is used to evaluate long bones with metastatic disease. Scoring &#x0003c;7 leads to a &#x0003c;10% fracture risk. A score of 8 has a 15% chance of fracture, and fixation should be considered. Scores &#x02265;9 have more than a 33% chance of fracture and should be seen by an orthopedist. Generally, scores &#x02265;8 should have an orthopedic consultation to assess prophylactic fixation.<xref ref-type="bibr" rid="article-140969.r23">[23]</xref></p>
          </list-item>
        </list>
        <list list-type="bullet">
          <list-item>
            <p><bold>Spinal instability neoplastic score:</bold>&#x000a0;A scoring system developed to assess vertebral metastases. This score takes into account the clinical and radiographic findings of the lesion. Points are assigned to the spinal location, with the junctional occiput scoring the highest, pain relief with lying down, bone lesion quality (lytic versus blastic), radiographic spinal alignment, percent of vertebral body collapse, and amount of posterolateral spinal involvement.&#x000a0;When all&#x000a0;6 components are combined, a score of 13 to 18 designates instability and should prompt a surgical consultation; scores between 7 and 12 are indeterminate and should involve a surgical consultation. Scores of &#x02264;6 are considered a stable spine.<xref ref-type="bibr" rid="article-140969.r24">[24]</xref></p>
          </list-item>
        </list>
        <p>
<bold>Interventional Radiology Techniques</bold>
</p>
        <p>The following interventional radiology techniques may also be utilized in patients with bone metastases:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>Embolization</bold>: This technique acts by decreasing the vascularization of bone lesions. Embolic agents (nano-particles) are injected after peripheral artery access to the desired arterial location.<xref ref-type="bibr" rid="article-140969.r25">[25]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Thermal ablation</bold>:&#x000a0;Radiofrequency, cryoablation, laser, or thermal ablation are various forms of this technique, which uses a variety of agents to induce a rapid temperature change in cells, leading to damage and necrosis.<xref ref-type="bibr" rid="article-140969.r26">[26]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Radiofrequency ablation</bold>:&#x000a0;Computed tomography guidance is utilized to place ablation probes in the center of the tumor.<xref ref-type="bibr" rid="article-140969.r27">[27]</xref>&#x000a0;The downside to this technique is potential pain, and patients typically need sedation or analgesia.</p>
          </list-item>
          <list-item>
            <p><bold>Microwave ablation</bold>: This technique typically provides faster coagulation and is less time-consuming than other techniques. Like radiofrequency ablation, an ablation probe is placed in the center of the tumor, and a set energy and time is used to complete the ablation.<xref ref-type="bibr" rid="article-140969.r28">[28]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Nonpercutaneous thermal ablation-high-intensity focused ultrasound ablation</bold>: This technique uses focused ultrasound beams backed by energy to burn the lesion that can be combined with magnetic resonance imaging-guided intensity-focused ultrasound as a noninvasive way of ablation to achieve coagulative necrosis.<xref ref-type="bibr" rid="article-140969.r29">[29]</xref></p>
          </list-item>
          <list-item>
            <p><bold>Cementoplasty:</bold>&#x000a0;Polymethyl methacrylate is injected into the bone portion weakened by metastasis. The compound acts to strengthen the bone to reduce pain.<xref ref-type="bibr" rid="article-140969.r30">[30]</xref><xref ref-type="bibr" rid="article-140969.r31">[31]</xref></p>
          </list-item>
        </list>
      </sec>
      <sec id="article-140969.s7" sec-type="Complications">
        <title>Complications</title>
        <p>Most adverse effects relate to the anatomic location treated and fraction used. The most common adverse effect after treatment is fatigue. Up to 35% of patients may experience a pain flare within the first week of treatment, which typically resolves in 3 days.<xref ref-type="bibr" rid="article-140969.r32">[32]</xref>&#x000a0;Oral dexamethasone 8 mg daily before treatment and for 4 days after can be used to limit pain flare.<xref ref-type="bibr" rid="article-140969.r33">[33]</xref>&#x000a0;Other adverse effects due to radiation of the spine include bowel-related symptoms (eg, nausea, diarrhea, or abdominal discomfort). The typical treatment regimen to alleviate nausea symptoms is prescribing 5-HT3 antagonists (ie, seratonin antagonists) before, during, and after treatment. Loperamide and hyoscine butylbromide may be used to treat diarrhea. Adverse effects generally resolve in 4 to 6 weeks after completion of therapy. Long-term complications are not common.<xref ref-type="bibr" rid="article-140969.r16">[16]</xref></p>
        <p>At times, repeated irradiation to the target lesion is required when the patient does not experience a response, pain recurs, or only a partial response is achieved. Up to 40% of patients do not obtain pain relief after initial therapy, and pain relapse is seen in 50% within&#x000a0;1 year of treatment.<xref ref-type="bibr" rid="article-140969.r34">[34]</xref>&#x000a0;No defined recommendation exists for reirradiation. A radiation oncologist should follow patients who have undergone repeated irradiation at their discretion.</p>
      </sec>
      <sec id="article-140969.s8" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>The use of palliative radiotherapy has increased as the population with cancer has been able to reach a higher life expectancy. A well-organized, interprofessional team approach is required to utilize radiotherapy effectively. Understanding the appropriate indication and patient selection for treatment is critical in limiting complications and damage to surrounding structures and improving overall patient quality of life. Clinicians taking care of cancer patients should fully comprehend the utility of palliative radiotherapy when discussing care plans with patients who are no longer systemic therapy or surgical candidates. Educating patients on the role of palliative therapy is of high importance. Patients must understand the intent of treatment is to improve quality of life, not necessarily improve survival. Though adverse effects occur in any treatment in medicine, palliative radiotherapy is often well-tolerated and individualized such that most patients can complete their proposed treatment plans.</p>
      </sec>
      <sec id="article-140969.s9" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>An interprofessional approach involving various healthcare professionals is vital for optimizing patient-centered care and outcomes related to palliative radiation therapy for bone metastases, consisting of medical oncologists, radiation oncologists, surgeons, pain management specialists, interventional radiologists, and palliative care clinicians. Effective communication and collaboration among these professionals are crucial for timely referral and patient selection, especially considering clinicians' challenges in identifying suitable candidates and involving radiation oncologists promptly. This collaborative effort aims to bridge the practice gap by effectively addressing variable referral patterns, disseminating guidelines, and rectifying misconceptions about treatment efficacy and adverse effects. By understanding the patient's primary cancer diagnosis, medical comorbidities, and life expectancy, healthcare professionals can tailor treatment plans to prevent further skeletal injury, alleviate symptoms, and enhance overall patient quality of life. Additionally, patient education regarding the role of palliative therapy is essential to align expectations and improve treatment adherence. Through interprofessional collaboration, healthcare professionals can optimize patient-centered care, improve outcomes, ensure patient safety, and effectively enhance team performance in managing bone metastases.</p>
      </sec>
      <sec id="article-140969.s10" sec-type="Nursing, Allied Health, and Interprofessional Team Monitoring">
        <title>Nursing, Allied Health, and Interprofessional Team Monitoring</title>
        <p>Patients should be followed after palliative radiotherapy treatments to monitor for adverse effects and to evaluate treatment effectiveness. Generally, patients should be seen by their medical oncologist, radiation oncologist, and other interprofessional team members to ensure patient safety and satisfaction.</p>
      </sec>
      <sec id="article-140969.s11">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=140969&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=140969">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/140969/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=140969">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-140969.s12">
        <title>References</title>
        <ref id="article-140969.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sousa</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cl&#x000e9;zardin</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Bone-Targeted Therapies in Cancer-Induced Bone Disease.</article-title>
            <source>Calcif Tissue Int</source>
            <year>2018</year>
            <month>Feb</month>
            <volume>102</volume>
            <issue>2</issue>
            <fpage>227</fpage>
            <page-range>227-250</page-range>
            <pub-id pub-id-type="pmid">29079995</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Coleman</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Croucher</surname>
                <given-names>PI</given-names>
              </name>
              <name>
                <surname>Padhani</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Cl&#x000e9;zardin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Fallon</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Guise</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Colangeli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Capanna</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Costa</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Bone metastases.</article-title>
            <source>Nat Rev Dis Primers</source>
            <year>2020</year>
            <month>Oct</month>
            <day>15</day>
            <volume>6</volume>
            <issue>1</issue>
            <fpage>83</fpage>
            <pub-id pub-id-type="pmid">33060614</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tsukamoto</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kido</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Tanaka</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Facchini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Peta</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rossi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
            </person-group>
            <article-title>Current Overview of Treatment for Metastatic Bone Disease.</article-title>
            <source>Curr Oncol</source>
            <year>2021</year>
            <month>Aug</month>
            <day>29</day>
            <volume>28</volume>
            <issue>5</issue>
            <fpage>3347</fpage>
            <page-range>3347-3372</page-range>
            <pub-id pub-id-type="pmid">34590591</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Igoumenou</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Angelini</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Baracco</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Benzakour</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Benzakour</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bork</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Vazifehdan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Nena</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Ruggieri</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Complications of spine surgery for metastasis.</article-title>
            <source>Eur J Orthop Surg Traumatol</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>30</volume>
            <issue>1</issue>
            <fpage>37</fpage>
            <page-range>37-56</page-range>
            <pub-id pub-id-type="pmid">31473821</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Quraishi</surname>
                <given-names>NA</given-names>
              </name>
              <name>
                <surname>Gokaslan</surname>
                <given-names>ZL</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>The surgical management of metastatic epidural compression of the spinal cord.</article-title>
            <source>J Bone Joint Surg Br</source>
            <year>2010</year>
            <month>Aug</month>
            <volume>92</volume>
            <issue>8</issue>
            <fpage>1054</fpage>
            <page-range>1054-60</page-range>
            <pub-id pub-id-type="pmid">20675746</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vazifehdan</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Karantzoulis</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Igoumenou</surname>
                <given-names>VG</given-names>
              </name>
            </person-group>
            <article-title>Surgical treatment for metastases of the cervical spine.</article-title>
            <source>Eur J Orthop Surg Traumatol</source>
            <year>2017</year>
            <month>Aug</month>
            <volume>27</volume>
            <issue>6</issue>
            <fpage>763</fpage>
            <page-range>763-775</page-range>
            <pub-id pub-id-type="pmid">28638950</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Pneumaticos</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sapkas</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Papagelopoulos</surname>
                <given-names>PJ</given-names>
              </name>
            </person-group>
            <article-title>Metastatic epidural spinal cord compression.</article-title>
            <source>Orthopedics</source>
            <year>2009</year>
            <month>Jun</month>
            <volume>32</volume>
            <issue>6</issue>
            <fpage>431</fpage>
            <page-range>431-9; quiz 440-1</page-range>
            <pub-id pub-id-type="pmid">19634817</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ratasvuori</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Wedin</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Keller</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Nottrott</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zaikova</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>Bergh</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Kalen</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nilsson</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Jonsson</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Laitinen</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Insight opinion to surgically treated metastatic bone disease: Scandinavian Sarcoma Group Skeletal Metastasis Registry report of 1195 operated skeletal metastasis.</article-title>
            <source>Surg Oncol</source>
            <year>2013</year>
            <month>Jun</month>
            <volume>22</volume>
            <issue>2</issue>
            <fpage>132</fpage>
            <page-range>132-8</page-range>
            <pub-id pub-id-type="pmid">23562148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Errani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Cosentino</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ciani</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Ferra</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Alfaro</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Bordini</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>C-reactive protein and tumour diagnosis predict survival in patients treated surgically for long bone metastases.</article-title>
            <source>Int Orthop</source>
            <year>2021</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>1337</fpage>
            <page-range>1337-1346</page-range>
            <pub-id pub-id-type="pmid">33392682</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Errani</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mavrogenis</surname>
                <given-names>AF</given-names>
              </name>
              <name>
                <surname>Cevolani</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Spinelli</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Piccioli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Maccauro</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Baldini</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Donati</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Treatment for long bone metastases based on a systematic literature review.</article-title>
            <source>Eur J Orthop Surg Traumatol</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>27</volume>
            <issue>2</issue>
            <fpage>205</fpage>
            <page-range>205-211</page-range>
            <pub-id pub-id-type="pmid">27650452</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Choong</surname>
                <given-names>PF</given-names>
              </name>
            </person-group>
            <article-title>The molecular basis of skeletal metastases.</article-title>
            <source>Clin Orthop Relat Res</source>
            <year>2003</year>
            <month>Oct</month>
            <issue>415 Suppl</issue>
            <fpage>S19</fpage>
            <page-range>S19-31</page-range>
            <pub-id pub-id-type="pmid">14600589</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Vakaet</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Boterberg</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <article-title>Pain control by ionizing radiation of bone metastasis.</article-title>
            <source>Int J Dev Biol</source>
            <year>2004</year>
            <volume>48</volume>
            <issue>5-6</issue>
            <fpage>599</fpage>
            <page-range>599-606</page-range>
            <pub-id pub-id-type="pmid">15349834</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Zeng</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Salvo</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Tsao</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Lutz</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Update on the systematic review of palliative radiotherapy trials for bone metastases.</article-title>
            <source>Clin Oncol (R Coll Radiol)</source>
            <year>2012</year>
            <month>Mar</month>
            <volume>24</volume>
            <issue>2</issue>
            <fpage>112</fpage>
            <page-range>112-24</page-range>
            <pub-id pub-id-type="pmid">22130630</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sze</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Shelley</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Held</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Mason</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2004</year>
            <volume>2002</volume>
            <issue>2</issue>
            <fpage>CD004721</fpage>
            <pub-id pub-id-type="pmid">15106258</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lehrer</surname>
                <given-names>EJ</given-names>
              </name>
              <name>
                <surname>Rosenberg</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Trifiletti</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Zaorsky</surname>
                <given-names>NG</given-names>
              </name>
            </person-group>
            <article-title>Toxicity after radiotherapy in patients with historically accepted contraindications to treatment (CONTRAD): An international systematic review and meta-analysis.</article-title>
            <source>Radiother Oncol</source>
            <year>2019</year>
            <month>Jun</month>
            <volume>135</volume>
            <fpage>147</fpage>
            <page-range>147-152</page-range>
            <pub-id pub-id-type="pmid">31015161</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Spencer</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Parrish</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Barton</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Henry</surname>
                <given-names>A</given-names>
              </name>
            </person-group>
            <article-title>Palliative radiotherapy.</article-title>
            <source>BMJ</source>
            <year>2018</year>
            <month>Mar</month>
            <day>23</day>
            <volume>360</volume>
            <fpage>k821</fpage>
            <pub-id pub-id-type="pmid">29572337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>De Felice</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Piccioli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Musio</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Tombolini</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>The role of radiation therapy in bone metastases management.</article-title>
            <source>Oncotarget</source>
            <year>2017</year>
            <month>Apr</month>
            <day>11</day>
            <volume>8</volume>
            <issue>15</issue>
            <fpage>25691</fpage>
            <page-range>25691-25699</page-range>
            <pub-id pub-id-type="pmid">28148890</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Maranzano</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Trippa</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Casale</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Costantini</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lupattelli</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bellavita</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Marafioti</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Pergolizzi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Santacaterina</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mignogna</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Silvano</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fusco</surname>
                <given-names>V</given-names>
              </name>
            </person-group>
            <article-title>8Gy single-dose radiotherapy is effective in metastatic spinal cord compression: results of a phase III randomized multicentre Italian trial.</article-title>
            <source>Radiother Oncol</source>
            <year>2009</year>
            <month>Nov</month>
            <volume>93</volume>
            <issue>2</issue>
            <fpage>174</fpage>
            <page-range>174-9</page-range>
            <pub-id pub-id-type="pmid">19520448</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Palma</surname>
                <given-names>DA</given-names>
              </name>
              <name>
                <surname>Salama</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>SS</given-names>
              </name>
              <name>
                <surname>Senan</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Treasure</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Govindan</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weichselbaum</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The oligometastatic state - separating truth from wishful thinking.</article-title>
            <source>Nat Rev Clin Oncol</source>
            <year>2014</year>
            <month>Sep</month>
            <volume>11</volume>
            <issue>9</issue>
            <fpage>549</fpage>
            <page-range>549-57</page-range>
            <pub-id pub-id-type="pmid">24958182</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ryu</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Deshmukh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Timmerman</surname>
                <given-names>RD</given-names>
              </name>
              <name>
                <surname>Movsas</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Gerszten</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Yin</surname>
                <given-names>FF</given-names>
              </name>
              <name>
                <surname>Dicker</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Abraham</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Zhong</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Shiao</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Tuli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Desai</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Mell</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Iyengar</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Hitchcock</surname>
                <given-names>YJ</given-names>
              </name>
              <name>
                <surname>Allen</surname>
                <given-names>AM</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Sharp</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Dunlap</surname>
                <given-names>NE</given-names>
              </name>
              <name>
                <surname>Siddiqui</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Pugh</surname>
                <given-names>SL</given-names>
              </name>
              <name>
                <surname>Kachnic</surname>
                <given-names>LA</given-names>
              </name>
            </person-group>
            <article-title>Stereotactic Radiosurgery vs Conventional Radiotherapy for Localized Vertebral Metastases of the Spine: Phase 3 Results of NRG Oncology/RTOG 0631 Randomized Clinical Trial.</article-title>
            <source>JAMA Oncol</source>
            <year>2023</year>
            <month>Jun</month>
            <day>01</day>
            <volume>9</volume>
            <issue>6</issue>
            <fpage>800</fpage>
            <page-range>800-807</page-range>
            <pub-id pub-id-type="pmid">37079324</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lutz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Balboni</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Jones</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Petit</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Rich</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Palliative radiation therapy for bone metastases: Update of an ASTRO Evidence-Based Guideline.</article-title>
            <source>Pract Radiat Oncol</source>
            <year>2017</year>
            <season>Jan-Feb</season>
            <volume>7</volume>
            <issue>1</issue>
            <fpage>4</fpage>
            <page-range>4-12</page-range>
            <pub-id pub-id-type="pmid">27663933</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lutz</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Berk</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Hahn</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Hoskin</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Howell</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Konski</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Kachnic</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Lo</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sahgal</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Silverman</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>von Gunten</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mendel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Vassil</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bruner</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Hartsell</surname>
                <given-names>W</given-names>
              </name>
              <collab>American Society for Radiation Oncology (ASTRO)</collab>
            </person-group>
            <article-title>Palliative radiotherapy for bone metastases: an ASTRO evidence-based guideline.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2011</year>
            <month>Mar</month>
            <day>15</day>
            <volume>79</volume>
            <issue>4</issue>
            <fpage>965</fpage>
            <page-range>965-76</page-range>
            <pub-id pub-id-type="pmid">21277118</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Johnson</surname>
                <given-names>SK</given-names>
              </name>
              <name>
                <surname>Knobf</surname>
                <given-names>MT</given-names>
              </name>
            </person-group>
            <article-title>Surgical interventions for cancer patients with impending or actual pathologic fractures.</article-title>
            <source>Orthop Nurs</source>
            <year>2008</year>
            <season>May-Jun</season>
            <volume>27</volume>
            <issue>3</issue>
            <fpage>160</fpage>
            <page-range>160-71; quiz 172-3</page-range>
            <pub-id pub-id-type="pmid">18521030</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fisher</surname>
                <given-names>CG</given-names>
              </name>
              <name>
                <surname>DiPaola</surname>
                <given-names>CP</given-names>
              </name>
              <name>
                <surname>Ryken</surname>
                <given-names>TC</given-names>
              </name>
              <name>
                <surname>Bilsky</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Shaffrey</surname>
                <given-names>CI</given-names>
              </name>
              <name>
                <surname>Berven</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Harrop</surname>
                <given-names>JS</given-names>
              </name>
              <name>
                <surname>Fehlings</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Boriani</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chou</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>MH</given-names>
              </name>
              <name>
                <surname>Polly</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Biagini</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Burch</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Dekutoski</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Ganju</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gerszten</surname>
                <given-names>PC</given-names>
              </name>
              <name>
                <surname>Gokaslan</surname>
                <given-names>ZL</given-names>
              </name>
              <name>
                <surname>Groff</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Liebsch</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Mendel</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Okuno</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Patel</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Rhines</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Rose</surname>
                <given-names>PS</given-names>
              </name>
              <name>
                <surname>Sciubba</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Sundaresan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Tomita</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Varga</surname>
                <given-names>PP</given-names>
              </name>
              <name>
                <surname>Vialle</surname>
                <given-names>LR</given-names>
              </name>
              <name>
                <surname>Vrionis</surname>
                <given-names>FD</given-names>
              </name>
              <name>
                <surname>Yamada</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Fourney</surname>
                <given-names>DR</given-names>
              </name>
            </person-group>
            <article-title>A novel classification system for spinal instability in neoplastic disease: an evidence-based approach and expert consensus from the Spine Oncology Study Group.</article-title>
            <source>Spine (Phila Pa 1976)</source>
            <year>2010</year>
            <month>Oct</month>
            <day>15</day>
            <volume>35</volume>
            <issue>22</issue>
            <fpage>E1221</fpage>
            <page-range>E1221-9</page-range>
            <pub-id pub-id-type="pmid">20562730</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sgalambro</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zugaro</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bruno</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Palumbo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Salducca</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Zoccali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Barile</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Masciocchi</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Arrigoni</surname>
                <given-names>F</given-names>
              </name>
            </person-group>
            <article-title>Interventional Radiology in the Management of Metastases and Bone Tumors.</article-title>
            <source>J Clin Med</source>
            <year>2022</year>
            <month>Jun</month>
            <day>07</day>
            <volume>11</volume>
            <issue>12</issue>
            <pub-id pub-id-type="pmid">35743336</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Dalili</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Isaac</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bazzocchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>&#x000c5;str&#x000f6;m</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Bergh</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Lalam</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weber</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Fritz</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Mansour</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. Ablation.</article-title>
            <source>Semin Musculoskelet Radiol</source>
            <year>2020</year>
            <month>Dec</month>
            <volume>24</volume>
            <issue>6</issue>
            <fpage>692</fpage>
            <page-range>692-709</page-range>
            <pub-id pub-id-type="pmid">33307585</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rybak</surname>
                <given-names>LD</given-names>
              </name>
            </person-group>
            <article-title>Fire and ice: thermal ablation of musculoskeletal tumors.</article-title>
            <source>Radiol Clin North Am</source>
            <year>2009</year>
            <month>May</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>455</fpage>
            <page-range>455-69</page-range>
            <pub-id pub-id-type="pmid">19361670</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Brace</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Laeseke</surname>
                <given-names>PF</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>LA</given-names>
              </name>
              <name>
                <surname>Frey</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>van der Weide</surname>
                <given-names>DW</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>FT</given-names>
              </name>
            </person-group>
            <article-title>Microwave ablation with multiple simultaneously powered small-gauge triaxial antennas: results from an in vivo swine liver model.</article-title>
            <source>Radiology</source>
            <year>2007</year>
            <month>Jul</month>
            <volume>244</volume>
            <issue>1</issue>
            <fpage>151</fpage>
            <page-range>151-6</page-range>
            <pub-id pub-id-type="pmid">17581900</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bazzocchi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Napoli</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Sacconi</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Battista</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Guglielmi</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Catalano</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Albisinni</surname>
                <given-names>U</given-names>
              </name>
            </person-group>
            <article-title>MRI-guided focused ultrasound surgery in musculoskeletal diseases: the hot topics.</article-title>
            <source>Br J Radiol</source>
            <year>2016</year>
            <volume>89</volume>
            <issue>1057</issue>
            <fpage>20150358</fpage>
            <pub-id pub-id-type="pmid">26607640</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <collab>Health Quality Ontario</collab>
            <article-title>Vertebral Augmentation Involving Vertebroplasty or Kyphoplasty for Cancer-Related Vertebral Compression Fractures: An Economic Analysis.</article-title>
            <source>Ont Health Technol Assess Ser</source>
            <year>2016</year>
            <volume>16</volume>
            <issue>12</issue>
            <fpage>1</fpage>
            <page-range>1-34</page-range>
            <pub-id pub-id-type="pmid">27293494</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Masala</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Chiocchi</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Taglieri</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Bindi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Nezzo</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>De Vivo</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Simonetti</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Combined use of percutaneous cryoablation and vertebroplasty with 3D rotational angiograph in treatment of single vertebral metastasis: comparison with vertebroplasty.</article-title>
            <source>Neuroradiology</source>
            <year>2013</year>
            <month>Feb</month>
            <volume>55</volume>
            <issue>2</issue>
            <fpage>193</fpage>
            <page-range>193-200</page-range>
            <pub-id pub-id-type="pmid">23014893</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zwaan</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Immunofluorescent studies on aphakia, a mutation of a gene involved in the control of lens differentiation in the mouse embryo.</article-title>
            <source>Dev Biol</source>
            <year>1975</year>
            <month>Jun</month>
            <volume>44</volume>
            <issue>2</issue>
            <fpage>306</fpage>
            <page-range>306-12</page-range>
            <pub-id pub-id-type="pmid">1093912</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Chow</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Meyer</surname>
                <given-names>RM</given-names>
              </name>
              <name>
                <surname>Ding</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nabid</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Chabot</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Ahmed</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Kuk</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Dar</surname>
                <given-names>AR</given-names>
              </name>
              <name>
                <surname>Mahmud</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Fairchild</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Wilson</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>JSY</given-names>
              </name>
              <name>
                <surname>Dennis</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Brundage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>DeAngelis</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Wong</surname>
                <given-names>RKS</given-names>
              </name>
            </person-group>
            <article-title>Dexamethasone in the prophylaxis of radiation-induced pain flare after palliative radiotherapy for bone metastases: a double-blind, randomised placebo-controlled, phase 3 trial.</article-title>
            <source>Lancet Oncol</source>
            <year>2015</year>
            <month>Nov</month>
            <volume>16</volume>
            <issue>15</issue>
            <fpage>1463</fpage>
            <page-range>1463-1472</page-range>
            <pub-id pub-id-type="pmid">26489389</pub-id>
          </element-citation>
        </ref>
        <ref id="article-140969.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huisman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van den Bosch</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wijlemans</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>van Vulpen</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>van der Linden</surname>
                <given-names>YM</given-names>
              </name>
              <name>
                <surname>Verkooijen</surname>
                <given-names>HM</given-names>
              </name>
            </person-group>
            <article-title>Effectiveness of reirradiation for painful bone metastases: a systematic review and meta-analysis.</article-title>
            <source>Int J Radiat Oncol Biol Phys</source>
            <year>2012</year>
            <month>Sep</month>
            <day>01</day>
            <volume>84</volume>
            <issue>1</issue>
            <fpage>8</fpage>
            <page-range>8-14</page-range>
            <pub-id pub-id-type="pmid">22300568</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
